Skip to content
Acticor Biotech logo

Acticor Biotech Alternatives & Competitors

12 companies similar to Acticor Biotech — To treat the acute phase of ischemic stroke !

Companies similar to Acticor Biotech

Alentis Therapeutics logo — alternative to Acticor Biotech

Alentis Therapeutics

We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis

PrecisemAb Biotech Co., Ltd. logo — alternative to Acticor Biotech

PrecisemAb Biotech Co., Ltd.

We are committed to changing the world to be better by creating safer and disease-directed...

NeuroTrauma Sciences, LLC logo — alternative to Acticor Biotech
Zhimeng Biopharma logo — alternative to Acticor Biotech

Zhimeng Biopharma

Actively advancing innovative small molecule treatments for neurological conditions like e...

Rival Readout

Competing with Acticor Biotech? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
RogCon, Inc. logo — alternative to Acticor Biotech

RogCon, Inc.

The SCN2A Company

ImmunGene logo — alternative to Acticor Biotech

ImmunGene

Innovation in antibody-cytokine fusion technology and monoclonal antibody-based therapies...

Emalex Biosciences logo — alternative to Acticor Biotech

Emalex Biosciences

Improving people's lives impacted by central nervous system disorders through meaningful s...

Algiax Pharmaceuticals logo — alternative to Acticor Biotech

Algiax Pharmaceuticals

Disarming chronic neuropathic pain

Myrobalan Therapeutics logo — alternative to Acticor Biotech

Myrobalan Therapeutics

Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS...

ImmunAbs Inc. logo — alternative to Acticor Biotech

ImmunAbs Inc.

ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture. "Hope f...

Zura Bio Limited (Nasdaq: ZURA) logo — alternative to Acticor Biotech

Zura Bio Limited (Nasdaq: ZURA)

Developing novel medicines for severe immune disorders

Newron Pharmaceuticals SpA logo — alternative to Acticor Biotech

Newron Pharmaceuticals SpA

The Specialist in CNS Drug Development

About Acticor Biotech

Acticor Biotech, a spin-off from Inserm (French National Institute of Health and Medical Research), is focused on developing an innovative therapeutic strategy for the acute phase of ischemic strokes, which constitute 80% of all strokes. The company's project addresses the pressing need for new therapeutic options to m...

Services

Drug development for thrombotic diseases

Target Customers

Patients suffering from acute ischemic stroke and cardiovascular emergencies

Business keywords

Biopharmaceuticals, Stroke Treatment, Thrombosis Therapy, Acute Phase Drug, Monoclonal Antibody, Drug Development, Innovative Therapy, Neurological Disorders, Biotechnology Research, Medical Research, Biomedical Science, Pharmaceutical Innovation

Frequently Asked Questions

Companies similar to Acticor Biotech include Alentis Therapeutics, PrecisemAb Biotech Co., Ltd., NeuroTrauma Sciences, LLC, Zhimeng Biopharma, RogCon, Inc.. They work in Biotechnology and Health and Wellness and share Acticor Biotech's focus on drug development, biopharmaceuticals and neurological disorders.
Bounce Watch lists 12 companies that share Acticor Biotech's industries and are closest to it in business tags, services, target customers, business model and size.
Acticor Biotech, a spin-off from Inserm (French National Institute of Health and Medical Research), is focused on developing an innovative therapeutic strategy for the acute phase of ischemic strokes, which constitute 80% of all strokes. The company's project addresses the pressing need for new therapeutic options to m...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Acticor Biotech: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Acticor Biotech on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 28 May 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout